Pfizer and Merck COVID-19 Drugs to Hit Commercial Market Nov. 1: Report by Technical Terrence Team 10/27/2023 0 Joe Raedle COVID-19 treatments manufactured by Pfizer (New York Stock Exchange:PFE) and Merck (New York Stock Exchange: MRK) will supposedly ...
Morningstar’s optimism about biotech; Pfizer is among the options by Technical Terrence Team 09/25/2023 0 Biotech stocks have suffered this year amid concerns about government moves to cap drug prices and scrutinize acquisitions. Investors are ...
Pfizer closes $43 billion acquisition deal with cancer drug maker Seagen by Technical Terrence Team 03/13/2023 0 Pfizer has been on an acquisition spree as it seeks to cushion the impact of a projected $17 billion drop ...
Pfizer, AbbVie, GSK, Eli Lilly among drugmakers to raise prices (NYSE:PFE) by Technical Terrence Team 01/15/2023 0 Sorry Pharmaceutical companies started 2023 strong, raising prices for about 450 drugs this month, with more price hikes expected, according ...
Google DeepMind's Gemma: Shattering expectations in AI with next-generation language models! 02/28/2024